If you have questions, please call us for more information about clinical trials or use our online form.
- Cancer clinical trials: 414-805-8900
- Noncancer clinical trials: 414-955-8555
Learn more about clinical trials basics and early-phase clinical trials, as well as some of the unique features our research program, including our Translational Research Unit. Froedtert & MCW health network is also part of the National Institutes of Health All of Us Research Program.
Displaying 61 - 70 of 269
A Phase 1/2 Umbrella Substudy of MK-5684-U01 Master Protocol to Evaluate the Safety and Efficacy of MK-5684-Based Treatment Combinations or MK-5684 Alone in Participants with Metastatic Castration-Resistant Prostate Cancer (mCRPC)
Objective
Safety and Efficacy of Opevesostat (MK-5684)-Based Treatment Combinations or Opevesostat Alone in Participants With Metastatic Castration-resistant Prostate Cancer (mCRPC)
Protocol No
MERCK-MK-5684-01A
Categories
Phase 3, Randomized, Double-Blind, Placebo-Controlled Multicenter Study of CVN424 in Parkinson's Disease Patients With Motor Complications
Objective
CVN424 in Parkinson's Disease Participants With Motor Complications
Protocol No
NEURO-CEREVANCE-CVN424-301
Establishing an AI-based Foundation for Remote Automated Speech and Language Therapy in Aphasia
Objective
PIC NAME AI
Protocol No
NEURO-IIT-ANDERSON-PICNAMEAI
A Double-Blind, Placebo-Controlled, Multicenter, Randomized Phase 3 Trial Evaluating the Efficacy and Safety of Felzartamab in Kidney Transplant Recipients with Late Antibody-Mediated Rejection (AMR) (TRANSCEND)
Objective
Felzartamab for the Treatment of Late Antibody-Mediated Rejection in Kidney Transplant Recipients
Protocol No
SURG-BIOGEN-TRANSCEND
Categories
The Efficacy of a Frequency-tuned Electromagnetic Field Treatment in Facilitating the Recovery of Subacute Ischemic Stroke Patients - a Pivotal Study (the "EMAGINE 2.0" Study)
Objective
Electromagnetic Field Ischemic Stroke - Novel Subacute Treatment - EMAGINE 2.0
Protocol No
PMR-BRAINQ-EMAGINE-2
Categories
A Randomized Phase III Trial of Doxorubicin + Pembrolizumab Versus Doxorubicin Alone for the Treatment of Undifferentiated Pleomorphic Sarcoma (UPS) and Related Poorly Differentiated Sarcomas
Objective
Study of immunotherapy + chemo for patients with aggressive poorly differentiated sarcomas
Protocol No
ECOG-EA7222
Brain Oxygen Optimization in Severe TBI (BOOST3): A Comparative Effectiveness Study to Test the Efficacy of a Prescribed Treatment Protocol Based on Monitoring the Partial Pressure of Brain Tissue Oxygen
Objective
Brain Oxygen Optimization in Severe TBI
Protocol No
EM-NINDS-BOOST3
Categories
Brain Alterations in Patients with Cushing's Disease: a Prospective Longitudinal Study
Objective
Cushing's Neurocognitive Study
Protocol No
ENDO-IIT-IOACHIMESCU-BACD
Categories
Renal Metabolism in Salt-Sensitive Human Blood Pressure
Objective
Renal Metabolism Study
Protocol No
ENDO-IIT-KIDAMBI-RENAL-METABOL
Categories
Liquid Biopsies to Evaluate the Dynamics of Sepsis
Objective
Liquid biopsies to evaluate the dynamics of sepsis
Protocol No
ENDO-IIT-SEMENKOVICH-DYSE
Categories